P. Lizarraga

Serological levels of mutated p53 protein are highly detected at early stages in breast cancer patients.

G. Balogh, D. Mailo, E. Barutta, 2010, Experimental and therapeutic medicine.

Mutant p 53 protein in serum could be used as a molecular marker in human breast cancer

L. Shulman, G. Balogh, D. Mailo, 2006 .

Mutant p53 protein in serum could be used as a molecular marker in human breast cancer.

L. Shulman, G. Balogh, D. Mailo, 2006, International journal of oncology.